Related Experiment Video
Updated: May 7, 2026
10:01
Development of Obliterative Bronchiolitis in a Murine Model of Orthotopic Lung Transplantation
Published on: July 10, 2012
20.3K
Thrombotic Microangiopathy: A Devastating Complication After Lung Transplantation
Wouter Rosseels1, Laurent Godinas2, Papay Jallah1
1Department of Nephrology and Renal Transplantation, UZ Leuven, Leuven, Belgium.
Transplantation Direct
|March 13, 2025
Summary
Thrombotic microangiopathy (TMA) after lung transplantation (LTx) is a severe complication linked to higher risks of kidney failure and death. Standardized diagnostic protocols are needed to improve outcomes for transplant patients.
Area of Science:
- Nephrology
- Pulmonology
- Transplantation Immunology
Background:
- Thrombotic microangiopathy (TMA) is a rare but serious complication following lung transplantation (LTx).
- The underlying causes and risk factors for TMA post-LTx are not well understood.
- This study investigates diagnostic accuracy, risk factors, and survival outcomes for TMA in lung transplant recipients.
Purpose of the Study:
- To evaluate diagnostic accuracy for TMA in lung transplant recipients.
- To identify risk factors associated with TMA development after LTx.
- To assess the impact of TMA on renal, pulmonary, and overall survival.
Main Methods:
- Retrospective case-control study of LTx patients with TMA from 2000 to 2021.
- Controls were matched for lung disease, demographics, CMV risk, and immunosuppression.
- Survival data were collected for all LTx patients.
Main Results:
- 29 TMA cases (2.9%) identified among 1025 LTx.
- TMA cases showed higher rates of HLA donor-specific antibodies, cytomegalovirus infection, and end-stage renal disease.
- TMA was associated with significantly lower time to chronic lung allograft dysfunction and higher overall mortality.
- Diagnostic workup for TMA was incomplete in over half of the cases.
Conclusions:
- TMA significantly increases the risk of end-stage renal disease and mortality post-LTx.
- Standardization of diagnostic criteria and screening protocols is crucial for TMA management.
- Identifying risk factors and temporal patterns aids in developing future treatment strategies for TMA.
Related Concept Videos
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
01:29Pulmonary Embolism I: Introduction
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
01:27Pulmonary Embolism III: Nursing Management
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
01:19Pulmonary Embolism I: Introduction
A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...